Wed 29 March |
|
DAY 1 | Auditorium | The Rosalind Franklin Room |
| ||
8:00 | 8:00: | ||||
8:10: | 8:10: | ||||
8:20: | 8:20: | ||||
8:30: | Registration and Coffee | 8:30: | |||
8:40: | 8:40: | ||||
8:50: | 8:50: | ||||
9:00 | 9:00: | ||||
9:10: | 9:10: | ||||
9:20: | 9:20: | ||||
9:30: | Research and Innovation 2023 – Accelerating future drug discovery Chairs: Roger Clark, Charles River Labs Saleha Patel, AstraZeneca |
9:30: | |||
9:40: | 9:40: | ||||
9:50: | 9:50: | ||||
10:00 | 10:00 | ||||
10:10 | 10:10 | ||||
10:20 | 10:20 | ||||
Refreshment Break | |||||
10:30 | 10:30 | ||||
10:40 | 10:40 | ||||
10:50 | 10:50 | ||||
11:00 | Synthetic biology: genetically programmed healthcare Chairs: Ron Weiss, Massachusetts Institute of Technology Simon Todd, AstraZeneca |
Ultra-rare disease drug discovery and personalized therapies Chairs: Joanne Hackett, IQVIA David Fischer, Charles River |
11:00 | ||
11:10 | 11:10 | ||||
11:20 | 11:20 | ||||
11:30 | 11:30 | ||||
11:40 | 11:40 | ||||
11:50 | 11:50 | ||||
12:00 | 12:00 | ||||
12:10 | CoSolve sustainability live pitching event - Novel solutions to enable organic solvent recycling from R&D processes Chairs: Kelly Gray, Emerging Innovations Unit, AstraZeneca |
12:10 | |||
12:20 | 12:20 | ||||
12:30 | 12:30 | ||||
12:40 | 12:40 | ||||
12:50 | 12:50 | ||||
1:00 | Refreshment Break - Poster Session 13.30 - 14.00 | 1:00: | |||
1:10: | 1:10: | ||||
1:20: | 1:20: | ||||
1:30: | 1:30: | ||||
1:40: | 1:40: | ||||
1:50: | 1:50: | ||||
2:00 | Synthetic biology: genetically programmed healthcare Chairs: Ron Weiss, Massachusetts Institute of Technology Simon Todd, AstraZeneca |
Ultra-rare disease drug discovery and personalized therapies Chairs: Joanne Hackett, IQVIA David Fischer, Charles River |
2:00: | ||
2:10: | 2:10: | ||||
2:20: | 2:20: | ||||
2:30: | 2:30: | ||||
2:40: | 2:40: | ||||
2:50: | 2:50: | ||||
3:00 | 3:00: | ||||
3:10: | 3:10: | ||||
3:20: | Refreshment Break | 3:20: | |||
3:30: | 3:30: | ||||
3:40: | 3:40: | ||||
3:50: | Synthetic biology: genetically programmed healthcare Chairs: Ron Weiss, Massachusetts Institute of Technology Simon Todd, AstraZeneca |
Ultra-rare disease drug discovery and personalized therapies Chairs: Joanne Hackett, IQVIA David Fischer, Charles River |
3:50: | ||
4:00 | 4:00: | ||||
4:10: | 4:10: | ||||
4:20: | 4:20: | ||||
4:30: | 4:30: | ||||
4:40: | 4:40: | ||||
4:50: | 4:50: | ||||
5:00 | 5:00: | ||||
Networking Event with Poster Session - 17.30 - 18.00 |
|||||
5:10: | 5:10: | ||||
5:20: | 5:20: | ||||
5:30: | 5:30: | ||||
5:40: | 5:40: | ||||
5:50: | 5:50: | ||||
6:00 | 6:00: | ||||
6:10: | 6:10: | ||||
6:20: | 6:20: | ||||
6:30: | 6:30: | ||||
6:40: | 6:40: | ||||
6:50: | 6:50: | ||||
7:00 | 7:00: |